BioTech Healthcare IT Life Science 
Healthcare IT Today
APRIL 4, 2025
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. In this episode I host Rony Angel from Centarix , a Jerusalem-based biotech company dedicated to longevity. Centarix is the only biotech I know that is bootstrapped – tell me how that happened?What
Healthcare IT Today
OCTOBER 24, 2024
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and life sciences sectors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
APRIL 25, 2024
Reflecting on AION Lab’s role in nurturing biotech startups, Gill underscores the company’s commitment to fostering innovation and supporting the growth of emerging ventures. Check our our video interview below to learn more about AION Labs approach to innovation in pharma and life sciences.
Healthcare IT Today
APRIL 4, 2023
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and life sciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
Healthcare IT Today
MARCH 22, 2023
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. The landscape of healthcare and biotechnology is changing at a rapid pace, with data taking center stage. This allows teams to quickly collaborate and share information on a joint virtual canvas.
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Healthcare IT Today
SEPTEMBER 13, 2024
The round was led by Eventide Asset Management (Eventide), which invests in biotech and life science healthcare companies seeking solutions for unmet clinical needs. million in Series B funding, bringing its total funding to date to $31.5
Expert insights. Personalized for you.
40 
Let's personalize your content